Mutliple defects of immune cell function in mice with disrupted interferon-γ genesDALTON, D. K; PITTS-MEEK, S; KESHAV, S et al.Science (Washington, D.C.). 1993, Vol 259, Num 5102, pp 1739-1742, issn 0036-8075Article

Regulation of neutrophil migration and superoxide production by recombinant tumor necrosis factors-α and -β: comparison to recombinant interferon-γ and interleukin-1αFIGARI, I. S; MORI, N. A; PALLADINO, M. A. JR et al.Blood. 1987, Vol 70, Num 4, pp 979-984, issn 0006-4971Article

The involvement of human tumor necrosis factors-α and β- in the mixed lymphocyte reactionREFAAT SHALABY, M; ESPEVIK, T; RICE, G. C et al.The Journal of immunology (1950). 1988, Vol 141, Num 2, pp 499-503, issn 0022-1767Article

Transforming growth factor-β₁ (TGF-β₁) and recombinant human tumor necrosis factor-α reciprocally regulate the generation of lymphokine-activated killer cell activity: comparison between natural porcine platelet-derived TGF-β₁ and TGF-β₂, and recombinant human TGF-β₁ESPEVIK, T; FIGARI, I. S; RANGES, G. E et al.The Journal of immunology (1950). 1988, Vol 140, Num 7, pp 2312-2316, issn 0022-1767Article

Characterization of the antitumor activities of human tumor necrosis factor-α and the comparison with other cytokines: induction of tumor-specific immunityPALLADINO, M. A. JR; REFAAT SHALABY, M; LIGGITT, D et al.The Journal of immunology (1950). 1987, Vol 138, Num 11, pp 4023-4032, issn 0022-1767Article

Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptorTARTAGLIA, L. A; GOEDDEL, D. V; REYNOLDS, C et al.The Journal of immunology (1950). 1993, Vol 151, Num 9, pp 4637-4641, issn 0022-1767Article

Protection against endotoxic schock by a tumor necrosis factor receptor immunoadhesinASHKENAZI, A; MARSTERS, S. A; CAPON, D.J et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 23, pp 10535-10539, issn 0027-8424Article

Immunoregulatory role of transforming growth factor β (TGF-β) in development of killer cells : comparison of active and latent TGF-β₁WALLICK, S. C; FIGARI, I. S; MORRIS, R. E et al.The Journal of experimental medicine. 1990, Vol 172, Num 6, pp 1777-1784, issn 0022-1007, 8 p.Article

Characterization of the in vitro and in vivo species preference of human and murine tumor necrosis factor-αKRAMER, S. M; AGGARWAL, B. B; EESSALU, T. E et al.Cancer research (Baltimore). 1988, Vol 48, Num 4, pp 920-925, issn 0008-5472Article

Inhibition of cytotoxic T cell development by transforming growth factor β and reversal by recombinant tumor necrosis factor αRANGES, G. E; FIGARI, I. S; ESPEVIK, T et al.The Journal of experimental medicine. 1987, Vol 166, Num 4, pp 991-998, issn 0022-1007Article

Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1DINARELLO, C. A; CANNON, J. G; WOLFF, S. M et al.The Journal of experimental medicine. 1986, Vol 163, Num 6, pp 1433-1450, issn 0022-1007Article

The two different receptors for tumor necrosis factor mediate distinct cellular responsesTARTAGLIA, L. A; WEBER, R. F; FIGARI, I. S et al.Proceedings of the National Academy of Sciences of the United States of America. 1991, Vol 88, Num 20, pp 9292-9296, issn 0027-8424Article

The autocrine production of transforming growth factor-β₁ during lymphocyte activation : a study with a monoclonal antibody-based ELISALUCAS, C; BALD, L. N; FENDLY, B. M et al.The Journal of immunology (1950). 1990, Vol 145, Num 5, pp 1415-1422, issn 0022-1767Article

Inhibition of cytokine production by cyclosporin A and transforming growth factor βESPEVIK, T; FIGARI, I. S; REFAAT SHALABY, M et al.The Journal of experimental medicine. 1987, Vol 166, Num 2, pp 571-576, issn 0022-1007Article

Recombinant human tumor necrosis factor-α: effects of proliferation of normal and transformed cells in vitroSUGARMAN, B. J; AGGARWAL, B. B; HASS, P. E et al.Science (Washington, D.C.). 1985, Vol 230, Num 4728, pp 943-945, issn 0036-8075Article